Difference between revisions of "WSI24-411-Case-4"

From MGH Learn Pathology
 
(One intermediate revision by the same user not shown)
Line 4: Line 4:
 
|intent=order
 
|intent=order
 
|category=409073007
 
|category=409073007
|occurrenceDateTime=2025-12-11T17:00:00+00:00
+
|occurrenceDateTime=2025-11-11T17:00:00+00:00
 
|basedOn=WSI24-411
 
|basedOn=WSI24-411
 
|priority=Routine
 
|priority=Routine
Line 15: Line 15:
 
|performer=Jt026
 
|performer=Jt026
 
|reasonCode=37 y.o. man with a history of testicular GCT containing teratoma, “somatic-type” RMS and ENET s/p orchiectomy + RPLND. Developed post-orchiectomy/RPLND recurrence treated with Etoposide + cisplatin + ifosfamide followed by Copanlesib (tumor showed a pathogenic PIK3CA variant). A complex multiorgan resection is performed to excise a large residual retroperitoneal mass.
 
|reasonCode=37 y.o. man with a history of testicular GCT containing teratoma, “somatic-type” RMS and ENET s/p orchiectomy + RPLND. Developed post-orchiectomy/RPLND recurrence treated with Etoposide + cisplatin + ifosfamide followed by Copanlesib (tumor showed a pathogenic PIK3CA variant). A complex multiorgan resection is performed to excise a large residual retroperitoneal mass.
|supportingInfo=Diagnosis
+
|supportingInfo=Low grade glial tumor of germ cell origin (likely maturation of ENT)
 
|identifier=WSI24-411-Case-4
 
|identifier=WSI24-411-Case-4
 
|access=Public
 
|access=Public

Latest revision as of 20:50, February 12, 2026

WSI24-411-Case-4
37 y.o. man with a history of testicular GCT containing teratoma, “somatic-type” RMS and ENET s/p orchiectomy + RPLND. Developed post-orchiectomy/RPLND recurrence treated with Etoposide + cisplatin + ifosfamide followed by Copanlesib (tumor showed a pathogenic PIK3CA variant). A complex multiorgan resection is performed to excise a large residual retroperitoneal mass.
Low grade glial tumor of germ cell origin (likely maturation of ENT)
December 11, 2025 12:00:00 PM